XML 30 R11.htm IDEA: XBRL DOCUMENT v3.21.2
Segment Information
6 Months Ended 12 Months Ended
Jun. 30, 2021
Dec. 31, 2020
Segment Information    
Segment Information

5.    Segment Information

The Company’s reportable segments are strategic business units that offer different products and have varied customer bases. There are four reportable segments: Chromaline, IKONICS Imaging, Digital Texturing (DTX) and Advanced Material Solutions (AMS). Chromaline sells screen printing film, emulsions, and inkjet receptive film primarily to distributors and some end users. IKONICS Imaging sells photo resistant film, art supplies, glass, and related abrasive etching equipment to both end users and distributors. AMS provides sound deadening and weight reduction technology to the aerospace industry along with products and services for etched composites, ceramics, glass and silicon wafers. DTX includes products and customers related to patented and proprietary inkjet technology used for mold texturing and prototyping. The accounting policies applied to determine the segment information are the same as those described in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020.

Management evaluates the performance of each segment based on the components of divisional income (loss). Assets and liabilities are not allocated to segments, except for trade receivables. Financial information with respect to the reportable segments follows:

For the three months ended June 30, 2021:

IKONICS

IKONICS

    

Chromaline

    

Imaging

    

DTX

    

AMS

    

Unalloc.

    

Total

Net sales

$

2,653,733

$

1,264,855

$

85,444

$

247,316

$

$

4,251,348

Cost of goods sold

 

1,905,738

 

644,071

 

34,260

 

237,975

 

 

2,822,044

Gross profit

 

747,995

 

620,784

 

51,184

 

9,341

 

 

1,429,304

Selling general and administrative*

 

289,928

 

259,219

 

32,001

 

58,869

 

1,304,485

 

1,944,502

Research and development*

 

 

 

 

 

128,895

 

128,895

Income (loss) from operations

$

458,067

$

361,565

$

19,183

$

(49,528)

$

(1,433,380)

$

(644,093)

For the three months ended June 30, 2020:

IKONICS

IKONICS

    

Chromaline

    

Imaging

    

DTX

    

AMS

    

Unalloc.

    

Total

Net sales

$

1,619,986

$

625,800

$

49,053

$

277,600

$

$

2,572,439

Cost of goods sold

 

1,407,362

 

419,985

 

24,346

 

335,851

 

 

2,187,544

Gross profit (loss)

 

212,624

 

205,815

 

24,707

 

(58,251)

 

 

384,895

Selling general and administrative *

 

366,136

 

224,573

 

30,059

 

57,035

 

524,504

 

1,202,307

Research and development*

 

 

 

 

 

201,234

 

201,234

Loss from operations

$

(153,512)

$

(18,758)

$

(5,352)

$

(115,286)

$

(725,738)

$

(1,018,646)

For the six months ended June 30, 2021:

    

IKONICS

IKONICS

    

Chromaline

    

Imaging

    

DTX

    

AMS

    

Unalloc.

    

Total

Net sales

$

4,352,414

$

2,351,456

$

161,755

$

459,131

$

$

7,324,756

Cost of goods sold

 

3,140,523

 

1,193,726

 

77,052

 

487,819

 

 

4,899,120

Gross profit (loss)

 

1,211,891

 

1,157,730

 

84,703

 

(28,688)

 

 

2,425,636

Selling general and administrative*

 

547,930

 

475,755

 

62,040

 

117,490

 

1,924,878

 

3,128,093

Research and development*

 

 

 

 

 

263,817

 

263,817

Income (loss) from operations

$

663,961

$

681,975

$

22,663

$

(146,178)

$

(2,188,695)

$

(966,274)

For the six months ended June 30, 2020:

    

IKONICS

IKONICS

    

Chromaline

    

Imaging

    

DTX

    

AMS

    

Unalloc.

    

Total

Net sales

$

3,584,326

$

1,595,899

$

161,582

$

727,824

$

$

6,069,631

Cost of goods sold

 

2,825,631

 

897,708

 

76,092

 

732,073

 

 

4,531,504

Gross profit (loss)

 

758,695

 

698,191

 

85,490

 

(4,249)

 

 

1,538,127

Selling general and administrative*

 

792,355

 

503,435

 

64,432

 

160,144

 

1,462,961

 

2,983,327

Research and development*

 

 

 

 

 

384,814

 

384,814

Income (loss) from operations

$

(33,660)

$

194,756

$

21,058

$

(164,393)

$

(1,847,775)

$

(1,830,014)

*

The Company does not allocate all selling, general and administrative expenses or any research and development expenses to its operating segments for internal reporting.

Trade receivables by segment as of June 30, 2021 and December 31, 2020 were as follows:

    

Jun 30, 2021

    

Dec 31, 2020

Chromaline

$

1,150,630

$

1,676,592

IKONICS Imaging

 

356,216

 

396,116

DTX

 

26,759

 

35,983

AMS

 

155,409

 

57,676

Unallocated

 

(37,979)

 

(47,154)

Total

$

1,651,035

$

2,119,213

5.           SEGMENT INFORMATION

The Company’s reportable segments are strategic business units that offer different products and have varied customer bases. There are four reportable segments: Chromaline, IKONICS Imaging, Digital Texturing (DTX) and Advanced Material Solutions (AMS). Chromaline sells screen printing film, emulsions, and inkjet receptive film primarily to distributors and some end users. IKONICS Imaging sells photo resistant film, art supplies, glass, and related abrasive etching equipment to both end users and distributors. AMS provides sound deadening and weight reduction technology to the aerospace industry along with products and services for etched composites, ceramics, glass and silicon wafers. DTX includes products and customers related to patented and proprietary inkjet technology used for mold texturing and prototyping.The accounting policies of the segments are the same as those described in the summary of significant accounting policies included in Note 1.

Management evaluates the performance of each segment based on the components of divisional income, and does not allocate assets and liabilities to segments except for trade receivables. Financial information with respect to the reportable segments follows:

For the year ended December 31, 2020:

    

    

IKONICS

    

    

    

    

Chromaline

Imaging

DTX

AMS

Unalloc.

Total

Net sales

$

8,475,743

$

3,709,318

$

294,929

$

952,230

 

$

$

13,432,220

Cost of goods sold

 

6,222,902

 

1,972,076

 

140,866

 

1,191,299

 

 

9,527,143

Gross profit (loss)

 

2,252,841

 

1,737,242

 

154,063

 

(239,069)

 

 

3,905,077

Selling, general, and administrative*

 

1,297,045

 

880,404

 

125,752

 

275,147

 

2,441,256

 

5,019,604

Research and development*

 

 

 

 

 

671,493

 

671,493

Income (loss) from operations

$

955,796

$

856,838

$

28,311

$

(514,216)

$

(3,112,749)

$

(1,786,020)

For the year ended December 31, 2019:

    

IKONICS

    

Chromaline

    

Imaging

    

DTX

    

AMS

    

Unalloc.

    

Total

Net sales

$

11,472,111

$

4,191,175

$

393,804

$

1,561,469

$

$

17,618,559

Cost of goods sold

 

8,389,404

 

2,273,641

 

157,650

 

1,400,675

 

 

12,221,370

Gross profit

 

3,082,707

 

1,917,534

 

236,154

 

160,794

 

 

5,397,189

Selling, general, and administrative*

 

1,832,473

 

1,081,847

 

149,924

 

361,342

 

2,058,000

 

5,483,586

Research and development*

 

 

 

 

 

870,279

 

870,279

Income (loss) from operations

$

1,250,234

$

835,687

$

86,230

$

(200,548)

$

(2,928,279)

$

(956,676)

*

The Company does not allocate all general and administrative expenses or any research and development expenses to its operating segments for internal reporting.

Trade receivables by segment as of December 31 were as follows:

    

Dec 31, 2020

    

Dec 31, 2019

Chromaline

$

1,676,592

$

1,916,066

IKONICS Imaging

 

396,116

 

304,791

DTX

 

35,983

 

13,919

AMS

 

57,676

 

252,363

Unallocated

 

(47,154)

 

(52,421)

Total

$

2,119,213

$

2,434,718